Hangzhou Tigermed Consulting Co 300347.SZ · CNY

Its shares trade on Shenzhen under the ticker 300347.SZ. It has been listed since 17 August 2012. In the fiscal year to 31 December 2025, it reported revenue of CN¥6.83bn and net income of CN¥887.9m. At that date it held total assets of CN¥28.36bn and shareholders' equity of CN¥20.96bn.

Hangzhou Tigermed Consulting Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2012-08-17. Hangzhou Tigermed Consulting Co Ltd is a company engaged in providing clinical trial services for research and development of new drugs. The firm operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Xiaoping YeChairman of the Board, since 2010CN¥3.2m
• Mr. Hao WuCo-President, Executive Director, Staff Elected Director, since 2021CN¥2.0m
• Ms. Chengcheng YangFinance DirectorCN¥1.6m
• Ms. Xiaochun CaoGeneral Manager, Director, since 2010CN¥1.1m
• Mr. Zengyu WenDeputy General Manager, Director, since 2023CN¥2.1m
• Ms. Xiaori LiSecretary of the BoardCN¥604,000
• Mr. Qiyu LiaoIndependent Non-Executive DirectorCN¥268,500
• Ms. Yuwen LiuIndependent Non-Executive DirectorCN¥216,200
• Mr. Huagang YuanIndependent Non-Executive DirectorCN¥260,600

Overall

87

Environment

77

Social

99

Governance

84

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.